LOC105375745: A Promising Drug Target and Biomarker (G105375745)

LOC105375745: A Promising Drug Target and Biomarker

LOC105375745 is a novel gene that has recently been identified as a potential drug target and biomarker. It is a non-coding RNA molecule that is located within the gene Expressed in the nucleus of human cells. LOC105375745 has been shown to play a critical role in the regulation of cell growth, apoptosis, and inflammation.

The Discovery of LOC105375745

LOC105375745 was first identified using transcriptomics techniques. RNA sequencing data analysis revealed that the gene was expressed in a wide range of tissues and cells, including brain, muscle, liver, and placenta. The gene was also shown to be highly expressed in cancer tissues, which suggests that it may be involved in the development and progression of cancer.

Follow-up studies have demonstrated that LOC105375745 is involved in the regulation of cell apoptosis. Apoptosis is a natural process that is involved in the elimination of damaged or dysfunctional cells. However, in cancer cells, apoptosis may be disrupted, leading to the survival and proliferation of these cells. Studies have shown that LOC105375745 is involved in the regulation of cell apoptosis by activating the Bcl-2 protein. Bcl-2 is a protein that has been shown to promote the survival of cancer cells by inhibiting apoptosis.

Another study has shown that LOC105375745 is involved in the regulation of cell proliferation. Proliferation is a critical process that is involved in the growth and development of cells, including cancer cells. Studies have shown that LOC105375745 is involved in the regulation of cell proliferation by activating the NF-kappa1 protein. NF-kappa1 is a protein that is involved in the regulation of cell proliferation and has been shown to promote the growth and survival of cancer cells.

In addition to its role in cell regulation, LOC105375745 has also been shown to be involved in the regulation of inflammation. Inflammation is a critical immune response that is involved in the regulation of tissue repair and protection. Studies have shown that LOC105375745 is involved in the regulation of inflammation by activating the NF-kappa-B protein. NF-kappa-B is a protein that is involved in the regulation of inflammation and has been shown to promote the production of pro-inflammatory cytokines.

Drug Targeting and Biomarker Potential

The potential drug targeting of LOC105375745 is based on its involvement in the regulation of cell apoptosis, proliferation, and inflammation. LOC105375745 has been shown to play a critical role in the regulation of cell apoptosis by activating the Bcl-2 protein. Bcl-2 is a protein that has been shown to promote the survival of cancer cells by inhibiting apoptosis.

The potential drug targeting of LOC105375745 may involve the use of small molecules or antibodies that are able to inhibit the activity of Bcl-2. This would result in the activation of apoptosis in cancer cells, leading to the loss of these cells and a reduction in the overall population of cancer cells.

In addition to its potential as a drug target, LOC105375745 has also been shown to be a potential biomarker for cancer. The regulation of cell apoptosis, proliferation, and inflammation is a critical process that is involved in the development and progression of cancer. Therefore, the regulation of these processes may be an attractive target for cancer biomarkers.

The identification of LOC105375745 as a potential drug target and biomarker highlights the importance of

Protein Name: Uncharacterized LOC105375745

The "LOC105375745 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105375745 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105375751 | LOC105375753 | LOC105375755 | LOC105375779 | LOC105375785 | LOC105375787 | LOC105375805 | LOC105375825 | LOC105375836 | LOC105375855 | LOC105375856 | LOC105375861 | LOC105375875 | LOC105375896 | LOC105375903 | LOC105375911 | LOC105375914 | LOC105375920 | LOC105375922 | LOC105375925 | LOC105375928 | LOC105375931 | LOC105375938 | LOC105375943 | LOC105375951 | LOC105375962 | LOC105375974 | LOC105375976 | LOC105375977 | LOC105375983 | LOC105375984 | LOC105375990 | LOC105375999 | LOC105376001 | LOC105376014 | LOC105376017 | LOC105376035 | LOC105376081 | LOC105376107 | LOC105376110 | LOC105376136 | LOC105376139 | LOC105376156 | LOC105376157 | LOC105376158 | LOC105376161 | LOC105376169 | LOC105376171 | LOC105376177 | LOC105376187 | LOC105376193 | LOC105376196 | LOC105376205 | LOC105376206 | LOC105376208 | LOC105376211 | LOC105376214 | LOC105376219 | LOC105376223 | LOC105376225 | LOC105376234 | LOC105376244 | LOC105376247 | LOC105376250 | LOC105376253 | LOC105376270 | LOC105376287 | LOC105376326 | LOC105376344 | LOC105376356 | LOC105376360 | LOC105376361 | LOC105376372 | LOC105376375 | LOC105376387 | LOC105376391 | LOC105376397 | LOC105376400 | LOC105376407 | LOC105376412 | LOC105376413 | LOC105376422 | LOC105376435 | LOC105376440 | LOC105376442 | LOC105376481 | LOC105376482 | LOC105376483 | LOC105376486 | LOC105376502 | LOC105376504 | LOC105376505 | LOC105376512 | LOC105376523 | LOC105376536 | LOC105376548 | LOC105376558 | LOC105376559 | LOC105376566 | LOC105376576